Managing Fatigue in Patients With Interstitial Lung Disease

Por Kahlmann, Vivienne, Moor, Catharina C., Wijsenbeek, Marlies S.
Publicado no Chest (2020)

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis

Por Wijsenbeek, Marlies S., Grutters, Jan C., Wuyts, Wim A.
Publicado no Adv Ther (2015)

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis

Por Moor, Catharina C., Gür-Demirel, Yasmin, Wijsenbeek, Marlies S.
Publicado no J Pers Med (2019)

Erectile dysfunction is a common problem in interstitial lung diseases

Por Fløe, Andreas, Hilberg, Ole, Wijsenbeek, Marlies, Bendstrup, Elisabeth
Publicado no Sarcoidosis Vasc Diffuse Lung Dis (2017)

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis

Por Moor, Catharina C., Heukels, Peter, Kool, Mirjam, Wijsenbeek, Marlies S.
Publicado no Front Med (Lausanne) (2017)

Comprehensive Care for Patients with Sarcoidosis

Por Moor, Catharina C., Kahlmann, Vivienne, Culver, Daniel A., Wijsenbeek, Marlies S.
Publicado no J Clin Med (2020)

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

Por Kreuter, Michael, Bonella, Francesco, Wijsenbeek, Marlies, Maher, Toby M., Spagnolo, Paolo
Publicado no Biomed Res Int (2015)

Optimizing quality of life in patients with idiopathic pulmonary fibrosis

Por van Manen, Mirjam J. G., Geelhoed, J. J. Miranda., Tak, Nelleke C., Wijsenbeek, Marlies S.
Publicado no Ther Adv Respir Dis (2017)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis

Por Glassberg, Marilyn K., Wijsenbeek, Marlies S., Gilberg, Frank, Petzinger, Ute, Kirchgaessler, Klaus-Uwe, Albera, Carlo
Publicado no Eur Respir J (2019)

Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

Por Noth, Imre, Wijsenbeek, Marlies, Kolb, Martin, Bonella, Francesco, Moros, Lizette, Wachtlin, Daniel, Corte, Tamera J.
Publicado no Eur Respir J (2019)

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease

Por Hoffmann-Vold, Anna-Maria, Allanore, Yannick, Bendstrup, Elisabeth, Bruni, Cosimo, Distler, Oliver, Maher, Toby M., Wijsenbeek, Marlies, Kreuter, Michael
Publicado no Respir Res (2020)

Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry

Por Moor, Catharina C., van den Berg, Carlijn A.L., Visser, Lidewij S., Aerts, Joachim G.J.V., Cottin, Vincent, Wijsenbeek, Marlies S.
Publicado no ERJ Open Res (2020)

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study

Por Wijsenbeek, Marlies, Bendstrup, Elisabeth, Valenzuela, Claudia, Henry, Michael T., Moor, Catharina, Bengus, Monica, Perjesi, Andras, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Vancheri, Carlo
Publicado no Adv Ther (2018)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis

Por van Manen, Mirjam J.G., Birring, Surinder S., Vancheri, Carlo, Vindigni, Virginia, Renzoni, Elisabetta, Russell, Anne-Marie, Wapenaar, Monique, Cottin, Vincent, Wijsenbeek, Marlies S.
Publicado no Eur Respir J (2017)

Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis

Por Jouneau, Stéphane, Crestani, Bruno, Thibault, Ronan, Lederlin, Mathieu, Vernhet, Laurent, Valenzuela, Claudia, Wijsenbeek, Marlies, Kreuter, Michael, Stansen, Wibke, Quaresma, Manuel, Cottin, Vincent
Publicado no Respir Res (2020)

Translation and validation of the King’s Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch

Por Wapenaar, Monique, Patel, Amit S, Birring, Surinder S, van Domburg, Ron T, Bakker, Eric WP, Vindigni, Virginia, Sköld, C Magnus, Cottin, Vincent, Vancheri, Carlo, Wijsenbeek, Marlies S
Publicado no Chron Respir Dis (2016)

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials

Por Kreuter, Michael, Wuyts, Wim A., Wijsenbeek, Marlies, Bajwah, Sabrina, Maher, Toby M., Stowasser, Susanne, Male, Natalia, Stansen, Wibke, Schoof, Nils, Orsatti, Leticia, Swigris, Jeffrey
Publicado no Respir Res (2020)

The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study

Por Wapenaar, Monique, Bendstrup, Elisabeth, Molina-Molina, Maria, Stessel, Maarten K.N., Huremovic, Jasmina, Bakker, Eric W., Kardys, Isabella, Aerts, Joachim G.J.V., Wijsenbeek, Marlies S.
Publicado no Sarcoidosis Vasc Diffuse Lung Dis (2020)

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and...

Por Maher, Toby M, Kreuter, Michael, Lederer, David J, Brown, Kevin K, Wuyts, Wim, Verbruggen, Nadia, Stutvoet, Simone, Fieuw, Ann, Ford, Paul, Abi-Saab, Walid, Wijsenbeek, Marlies
Publicado no BMJ Open Respir Res (2019)

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

Por Kahlmann, Vivienne, Janssen Bonás, Montse, Moor, Catharina C., van Moorsel, Coline H. M., Kool, Mirjam, Kraaijvanger, Raisa, Grutters, Jan C., Overgaauw, Mayka, Veltkamp, Marcel, Wijsenbeek, Marlies S.
Publicado no BMC Pulm Med (2020)